Table 3: Bioequivalence of SC and IM administration of alefacept


Pharmacokinetic parameter


n

Bioequivalence estimate


90 Percent CI

AUClast , h*μg/ml

42

104

97–112

Cmax, μg/ml

42

96

87–107

AUC¥, h*μg/ml

41a

103

96–111

AUC¥, area under the serum concentration-time curve to infinity; AUClast, area under the serum concentration-time curve to the last measurable value; CI, confidence interval; Cmax, peak serum concentration; IM, intramuscular; SC, subcutaneous.

aExcludes one subject for whom this parameter could not be estimated.